For many people, Tuesday’s election is truly a life-or-death matter
In Philly and elsewhere, undocumented immigrants anxiously wait for an election that could turn life upside down -- and they ...
Florida senators press HHS to use domestic IV manufacturers to ease shortages
Florida Sens. Marco Rubio (R) and Rick Scott (R) are questioning why the Biden administration hasn’t done more to leverage ...
Ozempic and Wegovy considered ‘available’ after more than 2 years in shortage
When reached for comment, an FDA spokesperson told The Hill, “The FDA is currently working to determine whether the demand or ...
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound ...
$35 insulin: Who in the US benefits?
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a major accomplishment of the Biden administration, referring to a provision of ...
Analysis
Post-Helene, patients who rely on IV nutrition face severe shortages
Hurricane Helene wrecked a Baxter International factory that produced 60 percent of the country’s IV fluids. Nearly 25,000 people who need IV nutrition are scrambling.
Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...